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CD4+ T cells are central to the adaptive im-
mune response. Naive CD4+ T cells can differ-
entiate into several distinct effector cell lineages 
(Murphy and Reiner, 2002). These include, but 
are not limited to, the original Th cell subsets, 
Th1 and Th2, and the more recently defined 
Th17, regulatory T cell (T reg cell), and T fol-
licular helper cell (Tfh cell) populations. Not 
surprisingly, each of these cell types harbors a 
somewhat unique gene expression profile. These 
distinct profiles are in part regulated by lineage-
defining transcription factors, sometimes deemed 
master regulators. These include T-bet for Th1 
cells, GATA-3 for Th2 cells, Foxp3 for T reg 
cells, ROR-t for Th17 cells, and more recently, 
the transcriptional repressor Bcl-6 for Tfh cells 
(Zheng and Flavell, 1997; Szabo et al., 2000; 
Hori et al., 2003; Ivanov et al., 2006; Johnston 
et  al.,  2009;  Nurieva  et  al.,  2009; Yu  et  al., 
2009a). The  diversity  of  expression  profiles   
allows each of these cell types to play roles in a 
variety of immune responses ranging from im-
mune tolerance to promoting antibody genera-
tion (Zhu et al., 2010).
The prevailing concept has been that each 
Th cell type is separate from the other lineages 
and strictly defined by the expression of lineage-
defining master regulator transcription factors. 
However, recent data suggest that determining 
whether these cell types represent a plastic sub-
set versus an endpoint lineage may not be that 
straightforward because of the fact that many of 
the  lineage-defining  factors  are  expressed  in 
multiple subsets of Th cells as well as more di-
vergent cell types (Zhu and Paul, 2010a,b). For 
example, the Th1 cell lineage–defining factor 
T-bet  is  expressed  at  varying  levels  in Th1,   
T reg, Th17, and Tfh cells (Szabo et al., 2000; 
Nurieva et al., 2009; Oldenhove et al., 2009; 
Wei  et  al.,  2009). These  studies  suggest  that   
instead  of  a  single  master  regulator  for  each   
lineage, the expression levels of, and potential 
interactions  between,  lineage-defining  tran-
scription factors may drive the overall develop-
ment  and  function  of  a  given  naive  CD4+  
T cell. This leads to the intriguing possibility 
that  the  simultaneous  expression  of  two  or 
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The T-box transcription factor T-bet is important for the differentiation of naive CD4+  
T helper cells (Th cells) into the Th1 phenotype. Much is known about T-bet’s role as a tran-
scriptional activator, but less is known about the mechanisms by which T-bet functionally 
represses alternative Th cell genetic programs. In this study, we first identify Socs1, Socs3, 
and Tcf7 (TCF-1) as gene targets that are negatively regulated by T-bet. Significantly, T-bet’s 
role in the repression of these genes is through a direct interaction with their promoters. 
Consistent with this, we identified two T-bet DNA-binding elements in the Socs1 promoter 
that are functionally used to down-regulate transcription in primary Th1 cells. Importantly,  
T-bet’s novel role in transcriptional repression is because of its ability to physically associate 
with, and functionally recruit, the transcriptional repressor Bcl-6 to a subset of promoters. 
Furthermore, T-bet functionally recruits Bcl-6 to the Ifng locus in late stages of Th1 differ-
entiation to repress its activity, possibly to prevent the overproduction of IFN-, which could 
result in autoimmunity. Collectively, these data establish a novel mechanism for T-bet–mediated 
gene repression in which two lineage-defining transcription factors, one a classical activator 
and one a repressor, collaborate to promote and properly regulate Th1 development.
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system to start to illuminate the detailed transcriptional regu-
lation mechanisms that T-bet utilizes to repress alternative Th 
cell genetic programs and ultimately promote Th1 cell lineage 
differentiation. First, similar to a previous study (Jenner et al., 
2009), we performed a microarray analysis comparing WT 
with T-bet/ CD4+ T cells skewed for 7 d in Th1 conditions 
to identify candidate targets for the in depth molecular ex-
periments. We identified several genes that had a higher ex-
pression level in T-bet/ as compared with WT Th1 cells, 
and we selected three for further analysis. Interestingly, the 
suppressor  of  cytokine  signaling  family  members  Socs1  and   
Socs3 were functionally repressed by T-bet expression in Th1 
more lineage-defining factors may promote plasticity be-
tween cell subsets dependent on the levels of each factor pres-
ent in a given condition (Zhou et al., 2009; O’Shea and Paul, 
2010). Therefore, more comprehensive studies addressing the 
molecular mechanisms by which these factors regulate gene 
expression both cooperatively and independently from one 
another are important for understanding the true capability   
of the cell.
The interplay between the expression, localization, and 
activity of specific transcription factors as well as their ability 
to bind to and influence the local chromatin structure deter-
mines the overall mechanisms of gene control during Th cell 
development. A subset of these transcription factors, includ-
ing the Th1 cell lineage–defining factor T-bet, are able to reg-
ulate both the activation and repression of genetic loci to 
promote the development of lineage-specific gene expression 
patterns (Finotto et al., 2002; Szabo et al., 2002; Djuretic et al., 
2007). Although much is known about how T-bet directly ac-
tivates a few prototypic Th1 target genes, surprisingly little is 
known about the identity of the genes silenced by T-bet and 
the mechanisms by which it down-regulates gene expression. 
In addition, it is still unclear whether T-bet is able to directly 
repress target genes or rather T-bet’s ability to functionally re-
press gene expression is strictly indirect (Hwang et al., 2005). 
Therefore, identifying genes that are repressed by T-bet is long 
overdue and will aid in understanding the mechanisms in-
volved in establishing Th cell genetic programs.
To begin to address these unanswered questions, we iden-
tified  three  biologically  important  genes,  Socs1,  Socs3,  and 
Tcf7, that were expressed at higher levels in T-bet–deficient 
CD4+ Th1 cells as compared with their WT counterparts. We 
show that the promoters of these genes are directly bound 
and functionally regulated by T-bet. The mechanisms by which 
T-bet functionally represses these genes are related to its phys-
ical association with the Tfh cell lineage–defining transcrip-
tional repressor, Bcl-6. Importantly, T-bet’s ability to associate 
with Bcl-6 allows T-bet, which normally serves as a transcrip-
tional activator, to instead effectively direct a specifically targeted 
gene repression program. Indeed, we demonstrate in primary 
Th1 cells that a Bcl-6 repressive complex is targeted by T-bet 
to the promoters of Socs1, Socs3, and Tcf7, which leads to their 
T-bet–dependent transcriptional repression during Th1 cell 
development. Finally, we show that Bcl-6 also is recruited to 
the Ifng locus in a T-bet–dependent manner during late time 
points of Th1 differentiation correlating with the loss of Ifng 
expression. Collectively, our study provides evidence for a 
mechanism of transcriptional repression in which two lineage-
defining factors collaborate to promote the development and 
proper functioning of a single Th cell lineage.
RESULTS
T-bet binds to the Socs1, Socs3, and Tcf7 promoter regions 
and represses their transcription
We first wanted to identify gene targets repressed by T-bet in 
Th1 cells for the purpose of subjecting them to comprehen-
sive transcriptional experiments. This will provide a model 
Figure 1.  T-bet binds to and represses the transcription of Socs1, 
Socs3, and Tcf7. (A) RNA was isolated from WT and T-bet–deficient pri-
mary CD4+ T cells either directly ex vivo or after polarization in Th1 condi-
tions for 7 d. Socs1, Socs3, and Tcf7 transcript levels were analyzed by 
quantitative RT-PCR. Results were normalized to the values obtained for 
Actb and are expressed as a ratio relative to the T-bet/ sample. (B) RNA 
was isolated from T-bet/ CD4+ T cells transduced with an empty expres-
sion vector or one containing T-bet. Transcript levels were determined by 
quantitative RT-PCR, and the data were normalized and represented as in 
A. (C) T-bet association with the promoters of Socs1, Socs3, and Tcf7 was 
assessed by ChIP. Chromatin was isolated from either WT or T-bet/ 
CD4+ T cells stimulated under Th1 conditions for 7 d. Chromatin samples 
were immunoprecipitated with antibodies to T-bet or a nonspecific anti-
body control. After purification, immunoprecipitated DNA was quanti-
tated by qPCR. qPCR signals were normalized to the nonspecific antibody 
control as well as a standardized aliquot of the input chromatin. (A–C) Data 
represent the mean of three (A and B) or five (C) independent experiments 
(error bars indicate SEM).JEM VOL. 208, May 9, 2011 
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T-bet recruits permissive chromatin-remodeling complexes 
to target promoters
Previous  studies  have  demonstrated  that T-bet  binding  to 
positively regulated target promoters leads to altered histone 
modifications that are consistent with a permissive chromatin 
environment. Specifically, T-bet physically recruits chromatin- 
modifying complexes to induce the permissive histone 3-lysine 
4 dimethyl (H3K4me2) mark and an SWI/SNF-dependent 
general  chromatin-remodeling  event  (Lewis  et  al.,  2007; 
Miller et al., 2008, 2010). It is possible that T-bet may recruit 
the same permissive chromatin-remodeling complexes to all 
target genes, with a downstream event accounting for target 
gene–specific  activation  versus  repression.  Alternatively,   
T-bet may functionally recruit a unique, repressive chromatin- 
remodeling complex to the repressed target genes to effec-
tively close the chromatin structure. To explore these possibil-
ities, we performed ChIP assays in the presence and absence   
of T-bet in primary Th1 cells to determine the relative levels of 
the permissive H3K4me2 modification. Importantly, at the 
negatively regulated Socs1, Socs3, and Tcf7 loci, as well as the 
positively  regulated Ifng  locus,  there  were  higher  levels  of   
the permissive H3K4me2 modification in WT Th1 cells in 
comparison with the T-bet/ Th1 cells (Fig. 2 A). Additionally, 
we used a restriction enzyme accessibility assay to measure the 
cells (Fig. 1 A). As their names suggest, Socs proteins are in-
volved in the inhibition of cytokine signaling pathways, 
and both Socs1 and Socs3 have been linked to the negative 
regulation of the canonical Th1 cytokine, IFN- (Alexander   
et al., 1999; Eyles et al., 2002; Seki et al., 2003; Yamamoto 
et al., 2003; Harada et al., 2007; Palmer and Restifo, 2009). 
In addition to Socs1 and Socs3, the gene Tcf7 was more 
highly expressed in T-bet/ Th1 cells (Fig. 1 A). Signifi-
cantly,  the  protein  product  of  theTcf7  gene, TCF-1,  is  a 
transcription factor that was recently shown to promote the 
development of the Th2 lineage (Yu et al., 2009b). Thus, the 
biological roles for Socs1, Socs3, and Tcf7 make them logical 
targets to be repressed by T-bet to promote Th1 differentia-
tion, and they provide a good model for determining the 
mechanisms by which T-bet mediates the repression of alter-
native Th cell fates.
To confirm that Socs1, Socs3, and Tcf7 were functionally 
repressed by T-bet, we performed a quantitative RT-PCR 
analysis comparing RNA isolated from WT or T-bet/ 
CD4+ T cells skewed under Th1 conditions for 7 d (Fig. 1 A). 
Consistently higher transcript levels for Socs1, Socs3, and Tcf7 
were detected in the T-bet–deficient cells as compared with 
their WT counterparts at day 7 of Th1 differentiation. As a 
control, we also examined gene expression directly ex vivo 
(day 0) in CD4+ T cells that did not yet express high levels 
of T-bet. Importantly, in these freshly isolated naive CD4+  
T cells, we observed no difference in Socs1, Socs3, or Tcf7 
transcript levels between WT and T-bet/ T cells. These 
results  suggest  that  the  expression  of  Socs1,  Socs3,  and   
Tcf7 is functionally repressed by T-bet during the course of   
Th1 differentiation.
To further confirm that the T-bet–dependent transcrip-
tional repression of these genes is cell intrinsic and not caused 
by another secondary defect in the T-bet/ cells, we per-
formed retroviral transduction experiments to express WT   
T-bet in T-bet/ CD4+ T cells. Consistent with a role for   
T-bet in repressing Socs1, Socs3, and Tcf7 gene transcription, 
retroviral transduction of T-bet into T-bet/ CD4+ T cells 
skewed in Th1 conditions caused a decrease in their expres-
sion as compared with an empty vector control (Fig. 1 B). 
Collectively, these data suggest that T-bet has the ability to 
functionally repress Socs1, Socs3, and Tcf7 transcription.
We next performed chromatin immunoprecipitation (IP 
[ChIP]) assays to examine whether T-bet associates with the 
Socs1, Socs3, and Tcf7 promoters to determine whether the   
T-bet–mediated functional repression may be the result of a 
direct role for T-bet. Importantly, T-bet associated with the 
promoter regions of Socs1, Socs3, and Tcf7 in primary CD4+ 
Th1 cells (Fig. 1 C). As negative controls, there were no de-
tectable signals in the T-bet–precipitated chromatin at these 
promoters in T-bet/ Th1 cells, and there was no enrich-
ment at a region upstream of the Socs1 promoter in the T-bet–
precipitated sample from the WT Th1 cells (Fig. 1 C). These 
data suggest that the repression of Socs1, Socs3, and Tcf7 has 
the potential to be, at least in part, caused by direct T-bet 
binding at each locus.
Figure 2.  The T-bet–dependent repression of Socs1, Socs3, and 
Tcf7 is independent of the chromatin environment and requires a 
corepressor. (A) H3K4me2 levels at the promoters of Socs1, Socs3, Tcf7, 
and Ifng were assessed by ChIP. Chromatin was isolated from either WT or 
T-bet/ CD4+ T cells skewed in Th1 conditions. Chromatin samples were 
immunoprecipitated with antibodies specific to the H3K4me2 mark or  
a nonspecific antibody control and quantitated as described in Fig. 1.  
(B) T-bet–dependent promoter-luciferase reporter activity was examined 
for Socs1, Socs3, Tcf7, and Ifng. EL4 T cells were transfected with the 
indicated pGL3 promoter-reporter construct and either an empty vector 
control (Cont.) or a T-bet expression plasmid. After P/I stimulation, lucifer-
ase values were measured and normalized to the activity obtained for a 
cotransfected renilla control. (A and B) Data represent the mean of four  
(A) or six (B) independent experiments (error bars indicate SEM). RLU, 
relative light units.1004 T-bet and Bcl-6 cooperate to repress transcription | Oestreich et al.
corepressor to inhibit gene expression. We next wanted to 
identify putative candidates that might contribute to the T-bet–
dependent repression of these target genes. To address this ques-
tion, we examined the composition of potential DNA-binding 
motifs for T-bet and transcriptional repressors in the Socs1 pro-
moter using a computer software program (Genomatix). Inter-
estingly, there are two putative T-bet binding sites as well as 
two potential binding elements for the transcriptional repres-
sor Bcl-6 in the Socs1 promoter (Fig. 3 A and Fig. S3). Signifi-
cantly, both the Socs3 and Tcf7 promoters also contain T-bet 
and Bcl-6 binding sites (Fig. S3 A).
To ascertain the role, if any, for these sites in Socs1 regula-
tion, we engineered truncation mutant Socs1 promoter-reporter 
constructs progressively deleting both the T-bet and Bcl-6 bind-
ing sites (Fig. 3 A). Intriguingly, progressive truncation of these 
sites enhanced promoter-reporter activity in comparison with 
the full-length Socs1 construct in both the EL4 cell line and 
primary Th1 cells (Fig. 3, B and C). These data indicate that a 
potential negative regulatory element may be located within 
this region (1 kb to 280 bp) of the Socs1 promoter.
Bcl-6 represses promoter activity of Socs1, Socs3, and Tcf7
Given the failure of T-bet overexpression alone to repress pro-
moter activity, we examined the functional consequence that 
Bcl-6 has on Socs1 promoter-reporter activity in the presence 
of T-bet (Fig. 3, D–F). We first examined Socs1 promoter-
reporter activity in response to Bcl-6 knockdown. Impor-
tantly, when a small interfering RNA (siRNA) specific to 
Bcl-6 was transfected in combination with T-bet, there was a 
modest enhancement of the Socs1 promoter-reporter activity 
when compared with cotransfection with a control siRNA 
(Fig. 3 D). Although the observed effect was modest, it was 
proportional to the knockdown in Bcl-6 levels in these cells 
(Fig. 3 E). Importantly, an increase in Tcf7 promoter-reporter 
activity was also observed upon Bcl-6 siRNA knockdown 
(Fig. S4 A). These data are consistent with a role for Bcl-6 in 
the repression of these genes.
To  complement  the  knockdown  results,  we  also  per-
formed overexpression experiments. Strikingly, simultaneous 
expression of Bcl-6 and T-bet substantially inhibited Socs1 
promoter activity in comparison with T-bet transfection alone 
(Fig. 3 F). Furthermore, Bcl-6 and T-bet overexpression also 
inhibited the activity of the Socs3 and Tcf7 promoter-reporter 
constructs. Importantly, expression of Bcl-6 alone only mini-
mally inhibited overall promoter activity in the absence of T-bet. 
Collectively, these data suggest that a combination of T-bet and 
Bcl-6 represses the promoter activity of Socs1, Socs3, and Tcf7.
T-bet–dependent repression is independent of Bcl-6  
DNA-binding activity
To ascertain whether the Bcl-6–mediated repression is caused 
by direct binding of Bcl-6 to the Socs1 promoter, we made a 
Socs1 promoter-reporter construct with mutations in the Bcl-6 
DNA-binding elements (Fig. 4 A and Fig. S3 B). Surprisingly, 
this mutant Socs1 promoter was still repressed by the si-
multaneous  overexpression  of T-bet  and  Bcl-6  (Fig.  4 A). 
T-bet and SWI/SNF-dependent general chromatin remodel-
ing at the promoters (Miller et al., 2010). In both primary 
Th1 cells that express T-bet and EL4 T cells transfected with 
a T-bet expression vector, we observed increased accessibility 
at the promoters of both the positively (Ifng) and negatively 
(Socs1, Socs3, and Tcf7) regulated target genes when com-
pared with their T-bet–deficient counterpart cells (Fig. S1). 
Collectively, these data suggest that T-bet functionally induces 
a more accessible chromatin environment independent from 
the final outcome on the target gene expression.
Overexpression of T-bet alone does not functionally repress 
Socs1, Socs3, and Tcf7 promoter activity
Another mechanism for T-bet–mediated gene repression could 
involve competition for an overlapping binding site. In this 
case, T-bet binding would displace a transcriptional activator 
by partially or completely blocking its binding site in the pro-
moter. In this scenario, T-bet expression alone would be suffi-
cient to repress the negatively regulated target genes. To test 
this mechanism, we cloned the Socs1, Socs3, and Tcf7 promot-
ers upstream of a luciferase reporter vector (pGL3) and per-
formed promoter-reporter assays. For comparison, we also 
examined an Ifng promoter-reporter construct, which is acti-
vated by T-bet (Shnyreva et al., 2004). The reporter con-
structs were cotransfected into EL4 T cells with either a T-bet   
expression plasmid or a control empty expression vector.   
Interestingly, T-bet overexpression resulted in enhanced pro-
moter-reporter activity for all promoters tested (Fig. 2 B).
It is important to note that the overexpression of T-bet 
causes the up-regulation of several endogenous T-bet target 
genes in EL4 cells including other transcription factors (Beima 
et al., 2006). Therefore, we hypothesized that the activation of 
the promoter-reporter constructs for the negatively regulated 
genes was most likely caused by the up-regulation of another 
secondary endogenous regulatory factor rather than the di-
rect transactivation capabilities of T-bet at their promoters. To 
test this possibility, we examined promoter-reporter activity 
in response to a T-bet mutant that cannot activate endogenous 
target genes. Importantly, this T-bet mutant is deficient in its 
ability to interact with chromatin-remodeling complexes but 
is still capable of binding to DNA and performing general 
chromatin-independent transactivation events (Miller et al., 
2008). The T-bet mutant construct did not activate the Socs1, 
Socs3, or Tcf7 promoters but was still able to induce activity of 
the Ifng promoter-reporter as a control (Fig. S2). These data 
suggest that the T-bet–dependent up-regulation of a second-
ary endogenous factor is responsible for the activation ob-
served  for  the  Socs1,  Socs3,  and  Tcf7  promoter-reporter 
constructs. Significantly, the T-bet mutant did not further re-
press the negatively regulated promoter-reporters, suggesting 
that T-bet alone does not inherently repress these promoters 
by blocking the binding of an essential activator (Fig. S2).
The data presented thus far strongly suggest that T-bet 
does not independently repress the transcription of these neg-
atively regulated gene targets. Rather, the data support a model 
in which T-bet may act in conjunction with a transcriptional JEM VOL. 208, May 9, 2011 
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data presented thus far demonstrating a functional role for   
T-bet in the repression of Socs1, Socs3, and Tcf7 in primary 
Th1 cells, we hypothesized that T-bet is required for the re-
cruitment of Bcl-6 to these loci.
To start to test this hypothesis, we first examined whether 
the putative T-bet DNA-binding elements are required for 
the negative regulation of the Socs1 promoter. Significantly, as 
the data from Fig. 3 indicate, there is an increase in Socs1 pro-
moter activity in the truncation constructs that do not con-
tain the T-bet binding elements. We next made a series of 
Socs1 reporter constructs mutating the most distal T-bet site 
(S1mut1), the most proximal T-bet site (S1mut2), or both   
in combination (S1mut1,2; Fig. S3 C). We transfected these   
T-bet point mutant constructs into EL4 cells in either the 
presence or absence of T-bet. Interestingly, the elimination of 
both T-bet binding sites in the S1mut1,2 construct resulted in 
a striking increase in Socs1 promoter activity, whereas the 
mutation of either T-bet site individually (S1mut1 or S1mut2) 
had little to no effect on promoter activity (Fig. 4 C). Impor-
tantly, we also examined the same Socs1 point mutant con-
structs in the more physiological setting of primary Th1 cells. 
Once again, the simultaneous mutation of both the proximal 
and distal T-bet sites led to a significant increase in promoter 
activity in comparison with the WT Socs1 promoter-reporter 
construct (Fig. 4 D). Consistent with the conclusion that the 
repression mediated through these T-box DNA-binding 
elements is T-bet dependent, we did not observe any 
enhancement of the Socs1 T-bet binding site mutant 
construct in comparison with the WT control in   
T-bet/ primary Th1 cells (Fig. 4 D vs. Fig. S7). These 
results suggest that the two T-bet binding elements are 
critical for the repression of the Socs1 promoter.
These data suggest that Bcl-6 may be functionally recruited 
to the Socs1 promoter by another factor. To confirm this un-
expected result and to rule out the possibility that a cryptic 
Bcl-6 DNA-binding element is found in the Socs1 promoter, 
we next created a Bcl-6 construct with a point mutation in its 
DNA-binding  domain. This  mutation  disrupts  the  DNA-
binding activity of Bcl-6 but keeps its transcriptional repres-
sion capacity intact (Mascle et al., 2003). Significantly, in the 
presence of T-bet, both WT Bcl-6 and the Bcl-6 DNA-binding 
mutant (Bcl6DBmut) repressed the T-bet–dependent activity of 
the Socs1 promoter to similar levels (Fig. 4 B and Fig. S5 B). 
In addition, both the Socs3 and Tcf7 promoter-reporters were 
repressed to an equivalent degree by the WT Bcl-6 and Bcl-6 
DNA binding–deficient proteins (Fig. 4 B). To further con-
firm these results, we also examined a second independent 
Bcl-6 DNA-binding point mutant construct and observed 
similar results (Figs. S5 and S6). Importantly, as a control, WT 
Bcl-6 but not the two Bcl6DBmut proteins repressed the pro-
moter activity of Gzmb, a known direct Bcl-6 gene target 
(Fig. S6; Yoshida et al., 2006). These data indicate that in con-
trast to Gzmb, the repressive capability of Bcl-6 at the Socs1, 
Socs3, and Tcf7 promoters does not require its direct DNA-
binding activity despite the presence of Bcl-6 DNA-binding 
elements. Rather, these data highly suggest that Bcl-6 is re-
cruited to these promoters by another factor. Because of the 
Figure 3.  Bcl-6 represses the promoter activity of Socs1, 
Socs3, and Tcf7. (A) The schematic indicates the location of 
predicted T-bet binding sites in the Socs1 promoter as well as 
the Socs1 truncation mutant constructs (see Fig. S3 for precise 
location). (B and C) EL4 (B) or primary WT Th1 (C) cells were 
transfected with the indicated Socs1 truncation or full-length 
promoter-reporter construct. In addition, EL4 cells were cotrans-
fected with either an empty expression vector (control) or one 
expressing T-bet. Luciferase reporter activity was normalized to 
the activity obtained for the cotransfected renilla control.  
(D) EL4 cells were transfected with the Socs1 promoter-reporter 
in conjunction with a control or T-bet expression vector and a 
control siRNA (siGFP) or one specific to Bcl-6 (siBcl6). After P/I 
stimulation, luciferase promoter-reporter values were normal-
ized to the renilla control. (E) EL4 cells were transfected and 
treated as in D. RNA was isolated, and Bcl6 transcript levels were 
analyzed by quantitative RT-PCR. Results were normalized to the 
values obtained for Actb and are expressed as a ratio relative to 
the control sample. (F) EL4 T cells were cotransfected with the 
indicated pGL3 promoter-reporter construct and an empty vec-
tor control, T-bet, Bcl-6, or T-bet and Bcl-6 in combination. After 
P/I stimulation, luciferase promoter-reporter values were nor-
malized to the renilla control. (B–F) Data represent the mean of 
three (B–E) or four (F) independent experiments (error bars indi-
cate SEM). RLU, relative light units.1006 T-bet and Bcl-6 cooperate to repress transcription | Oestreich et al.
for the recruitment of Bcl-6 to these promoters in 
Th1 cells, we performed ChIP experiments to exam-
ine Bcl-6 association with the Socs1, Socs3, and Tcf7 
promoters in WT versus T-bet/ primary Th1 cells. 
Significantly, there was a higher level of Bcl-6 associa-
tion with all three promoters in the WT versus T-bet/ 
Th1 cells (Fig. 5 A). As a negative control, we did not 
detect Bcl-6 at a location upstream of the Socs1 pro-
moter (which also is not bound by T-bet; Fig. 1 C), indicating 
that the targeting of Bcl-6 is specific to the T-bet–bound area 
in the promoter region. As an additional control, the protein 
and RNA expression levels of Bcl-6 were similar in WT and 
T-bet/ Th1 cells (Fig. S8), indicating that alterations in the 
amount of Bcl-6 present in each cell type cannot explain the 
observed differences. Collectively, these data strongly suggest 
that the recruitment of Bcl-6 to the Socs1, Socs3, and Tcf7 
promoters is dependent on the presence of T-bet.
T-bet and Bcl-6 physically interact to repress transcription
Collectively, the aforementioned data suggest that T-bet is re-
quired to recruit Bcl-6 to the negatively regulated promoters. 
We next wanted to determine whether T-bet targets Bcl-6 to 
these promoters by physically interacting with Bcl-6. To start 
to test this possibility, we performed a co-IP experiment in 
which we cotransfected EL4 T cells with T-bet in combina-
tion with either an empty vector construct or one expressing 
Bcl-6. Importantly, T-bet specifically precipitated with Bcl-6, 
indicating that T-bet and Bcl-6 can be found in the same 
complex in this overexpression system (Fig. 5 B). We then 
We next wanted to determine whether the repressive ca-
pability of Bcl-6 requires a T-bet–dependent activity. To test 
this possibility, we transfected WT versus T-bet/ primary 
Th1 cells with either a control siRNA or one specific to   
Bcl-6. In WT Th1 cells, the knockdown of Bcl-6 enhanced 
Socs1 promoter-reporter activity (Fig. 4 E). Significantly, Bcl-6 
knockdown had no effect on Socs1 activity in the absence of 
T-bet in the T-bet/ Th1 cells (Fig. 4 F). Importantly, the 
Bcl-6 knockdown levels were equivalent in WT and T-bet/ 
Th1 cells, with the degree of Bcl-6 reduction proportional to 
the enhancement of Socs1 promoter-reporter activity in the 
WT cells (Fig. 4, E and F). Collectively, these data suggest that 
the Bcl-6–mediated repression of the Socs1 promoter is de-
pendent on T-bet.
T-bet recruits Bcl-6 to the Socs1, Socs3, and Tcf7 
promoters in Th1 cells
The data we have presented thus far strongly imply that both 
a T-bet DNA binding–dependent and a Bcl-6 DNA binding–
independent activity are necessary for the repression of the 
Socs1, Socs3, and Tcf7 genes. To test whether T-bet is required 
Figure 4.  Bcl-6–dependent repression of Socs1, Socs3, 
and Tcf7 is independent of Bcl-6 DNA binding. (A) The Socs-
1Bcl6mut1,2 or WT promoter-reporter constructs were cotrans-
fected with an empty expression vector (control), T-bet, or T-bet 
and Bcl-6. (See Fig. S3 for precise location of the Bcl-6 binding 
site mutations in the Socs1Bcl6mut1,2 construct.) (B) EL4 T cells 
were transfected with the indicated pGL3 promoter construct 
and an empty vector control, T-bet, T-bet and Bcl-6, or T-bet and 
the Bcl-6 DNA-binding mutant (Bcl6DBmut). (C) The indicated 
Socs1 point mutants (in T-bet binding sites) or WT promoter-
reporter constructs were cotransfected with either an empty 
expression vector (control) or one expressing T-bet. (A–C) The 
samples were stimulated with P/I, and the reporter activity was 
measured and normalized to the activity of a renilla control.  
(D) The indicated Socs1 point mutant (in T-bet binding sites) or 
WT promoter-reporter constructs were transfected into primary 
WT Th1 cells. After overnight incubation, reporter activity was 
measured and normalized to a renilla control. (E and F) Primary 
WT (E) or T-bet/ (F) Th1 cells were transfected with the Socs1 
promoter-reporter and either a control siRNA (siGFP) or one 
specific to Bcl-6 (siBcl6). Luciferase promoter-reporter values 
were normalized to the renilla control. RNA was isolated from 
the primary Th1 cells, and Bcl6 transcript levels were analyzed by 
quantitative RT-PCR. Results were normalized to the values ob-
tained for Actb and are expressed as a ratio relative to the con-
trol sample. (A–F) Data represent the mean of three (A and D) or 
four (B, C, E, and F) independent experiments (error bars indicate 
SEM). RLU, relative light units.JEM VOL. 208, May 9, 2011 
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form  a  repressive  complex  to  inhibit  the  transcription  of 
Socs1, Socs3, and Tcf7.
The C-terminal domain of Bcl-6, which contains six zinc 
fingers, is required for its association with T-bet
We next wanted to determine which domain or domains 
within Bcl-6 mediate its interaction with T-bet. To accom-
plish this, we created Bcl-6 truncation constructs and tested 
their ability to form a complex with T-bet in EL4 co-
IP experiments (Fig. 6 A). A Bcl-6 construct lacking 
the repressive BTB/POZ domain still associated with 
T-bet, with only a modest reduction in its interaction 
as compared with WT Bcl-6 (Fig. 6 B). Interestingly, 
Bcl-6 mutant constructs with a C-terminal truncation 
deleting its six zinc fingers were no longer able to 
wanted to explore whether T-bet and Bcl-6 form a stable 
complex at their endogenous expression levels in primary 
CD4+ Th1 cells. In co-IP experiments, T-bet coprecipitated 
with Bcl-6 in WT Th1 cells (Fig. 5 C). As a negative control, 
the T-bet signal was not detected in either WT Th1 cells   
immunoprecipitated with a nonspecific antibody control or 
in T-bet/ CD4+ Th1 cells (Fig. 5 C). Collectively, these ex-
periments suggest that T-bet and Bcl-6 have the ability to 
Figure 5.  Bcl-6 is recruited to the pro-
moters of Socs1, Socs3, and Tcf7 through 
a physical interaction with T-bet in Th1 
cells. (A) Chromatin was isolated from either 
WT or T-bet/ CD4+ T cells stimulated in Th1 
conditions for 7 d. Chromatin samples were 
immunoprecipitated with either an antibody 
to Bcl-6 or a nonspecific antibody control. 
Immunoprecipitated DNA was quantitated by 
qPCR and normalized to the nonspecific anti-
body control as well as a standardized aliquot 
of the input chromatin. Data represent the 
mean of five independent experiments (error 
bars indicate SEM). (B) EL4 T cells were trans-
fected with an untagged T-bet expression 
construct in combination with either a V5 
epitope–tagged Bcl-6 expression vector or 
empty vector control. Lysates were prepared and immunoprecipitated with an antibody for the V5 epitope tag and then probed with a T-bet–specific anti-
body. (C) Lysates from either WT or T-bet/ primary Th1 cells were immunoprecipitated with either a Bcl-6 (lanes 5 and 6) or control antibody (lane 4). 
After IP, a Western blot analysis was performed with a T-bet–specific antibody. (B and C) Data are representative of three (B) or five (C) independent ex-
periments. IB, immunoblot.
Figure 6.  The C-terminal zinc finger domain of Bcl-6 is 
required for its association with T-bet. (A) The schematic 
indicates the location of the primary functional domains con-
tained within Bcl-6. These include an N-terminal BTB/POZ do-
main, a C-terminal domain containing six individual zinc fingers 
(displayed as gray ovals), and a centrally located PEST domain. 
Diagrams of the Bcl-6 truncation mutant constructs are shown 
below the WT schematic. (B) EL4 T cells were transfected with an 
untagged T-bet expression construct in combination with V5 
epitope–tagged WT Bcl-6 (lanes 1 and 5) or the Bcl-6 truncation 
mutant expression vectors as indicated (lanes 2–4 and 6–8). 
Lysates were prepared and immunoprecipitated with an anti-
body to T-bet (lanes 5–8). The blot was then probed with a V5 
epitope tag–specific antibody. Data are representative of three 
independent experiments. (C) EL4 T cells were transfected with 
the full-length Socs1 promoter-reporter construct and an empty 
vector control, T-bet, T-bet and Bcl-6, or T-bet and the indicated 
Bcl-6 truncation mutants. After P/I stimulation, luciferase pro-
moter-reporter values were normalized to the renilla control. 
Data represent the mean of three independent experiments (error 
bars indicate SEM). IB, immunoblot; RLU, relative light units.1008 T-bet and Bcl-6 cooperate to repress transcription | Oestreich et al.
To begin to test this possibility, we analyzed the time course 
of Ifng expression during Th1 differentiation. We observed 
high levels of Ifng transcripts at day 3 and a subsequent decrease 
in transcript levels by day 7 of Th1 differentiation (Fig. 7 D). 
associate with T-bet (Fig. 6 B). These data suggest that the   
C-terminal domain of Bcl-6 is required for its interaction 
with T-bet. This is an intriguing result because the six zinc 
fingers within this domain are known to mediate both DNA 
binding as well as other protein–protein interactions (Mascle 
et al., 2003). It will be important to determine in future ex-
periments whether the association between T-bet and Bcl-6 
impedes the DNA-binding activity of Bcl-6, which could 
preferentially redirect its targeting to T-bet binding elements.
We next assessed the functional role for each domain in 
mediating T-bet–dependent repression. Significantly, the Bcl-6 
C-terminal zinc finger truncation constructs defective in 
their ability to associate with T-bet no longer repressed Socs1 
promoter-reporter activity (Fig. 6 C). In addition, the Bcl-6 
BTB/POZ domain truncation also could not repress Socs1 
promoter-reporter activity (Fig. 6 C). This is consistent with the 
required role for the BTB/POZ domain in the repressive capa-
bility of Bcl-6 (Basso and Dalla-Favera, 2010). We also observed 
similar losses of repressive capabilities for the Bcl-6 trunca-
tions at the Tcf7 promoter (Fig. S9). Collectively, these data 
are consistent with the hypothesis that Bcl-6 is functionally 
recruited by T-bet to repress the activity of these promoters.
Bcl-6 also represses Ifng, a target gene positively  
regulated by T-bet
We next sought to determine whether Bcl-6 plays a role in 
regulating genes that are normally activated by T-bet in Th1 
cells. To accomplish this goal, we first examined the effect of 
Bcl-6 overexpression on T-bet–dependent Ifng promoter- 
reporter activity. Interestingly, Bcl-6 repressed the T-bet– 
dependent activation of the Ifng promoter similar to its functional 
effect at the Socs1, Socs3, and Tcf7 promoters (Fig. 7 A). In addi-
tion, the knockdown of Bcl-6 also enhanced the T-bet– 
dependent activation of the Ifng promoter-reporter construct 
(Fig. S4). To assess whether Bcl-6 has the same effect on Ifng 
transcription in the context of the chromatin environment, 
we overexpressed T-bet either alone or in combination with 
Bcl-6  and  assessed  endogenous  Ifng  gene  transcripts  by 
quantitative RT-PCR. Significantly, Bcl-6 also repressed the   
T-bet–dependent activation of endogenous Ifng gene expres-
sion (Fig. 7 B). These results suggest that Bcl-6 plays a role in 
the functional repression of both the genes that are positively 
and negatively regulated by T-bet.
These intriguing observations led us to examine whether 
Bcl-6 may play a role in regulating Ifng expression during 
primary Th1 cell differentiation. We first wanted to deter-
mine whether Bcl-6 is present at the Ifng promoter in pri-
mary Th1 cells. Interestingly, in a ChIP analysis comparing 
WT with T-bet/ Th1 cells (day 7), similar to the negatively 
regulated targets, Bcl-6 associated with the Ifng promoter in a 
T-bet–dependent manner (Fig. 7 C). Given these results, we 
hypothesized that the Bcl-6 association with the Ifng locus 
may temper its expression. If this is the case, Bcl-6 may be 
mechanistically down-regulating Ifng in the late stages of the 
Th1 effector cell to prevent the overproduction of IFN-, which 
could result in potential T cell–mediated autoimmune diseases. 
Figure 7.  T-bet–dependent recruitment of Bcl-6 to the Ifng  
promoter in late time points of Th1 culture correlates with a  
reduction in Ifng gene transcription. (A) EL4 T cells were cotransfected 
with the indicated pGL3 promoter-reporter construct and an empty ex-
pression vector control, T-bet, or T-bet and Bcl-6. After P/I stimulation, 
luciferase values were measured and normalized to a renilla control.  
(B) EL4 T cells were transfected and treated as in A followed by RNA isola-
tion. A quantitative RT-PCR analysis to determine endogenous Ifng tran-
script levels was performed and normalized to Actb. (C) Chromatin was 
isolated from either WT or T-bet/ CD4+ T cells at day 3 or 7 of Th1 dif-
ferentiation. Chromatin samples were immunoprecipitated with either an 
antibody to Bcl-6 or a nonspecific antibody control. Immunoprecipitated 
DNA was quantitated by qPCR with signals for the Ifng promoter normal-
ized to the nonspecific antibody control as well as a standardized aliquot 
of the input chromatin. (D) RNA samples were isolated from WT CD4+  
T cells at days 3 and 7 of Th1 differentiation. A quantitative RT-PCR analy-
sis was performed to determine Ifng transcript levels, and results were 
normalized to Actb. The data are represented as fold change over the Ifng 
transcript levels at day 0. (E) The Ifng promoter-reporter construct was 
transfected into primary Th1 cells at days 3 and 7 of Th1 differentiation. 
After overnight incubation, luciferase values were measured and normal-
ized to both empty vector (pGL3) and renilla controls. (F) ChIP samples 
were treated and analyzed as in C with the exception that a T-bet anti-
body was used for IP. (A–F) Data represent the mean of four (A, C, and F) 
or three (B, D, and E) independent experiments (error bars indicate SEM). 
RLU, relative light units.JEM VOL. 208, May 9, 2011 
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factors in a single Th cell type, now strongly suggest that the 
notion of one unique master regulator per Th cell type may 
not be entirely accurate (Zhou et al., 2009; O’Shea and Paul, 
2010; Zhu and Paul, 2010b). Instead, the regulation of critical 
lineage-defining factors by each other and the interactions 
between them are clearly important aspects in determining 
Th cell fate. For example, it is known that Th1 cells express 
high levels of T-bet and low levels of Bcl-6, whereas the 
reverse scenario is found in Tfh cells (Johnston et al., 2009; 
Nurieva et al., 2009; Yu et al., 2009a). Our data suggest that 
when T-bet is in excess, it will target the available Bcl-6 to a 
subset of promoters that are preferentially repressed during 
the later stages of Th1 development. Furthermore, these data 
argue that a simple change in the expression levels of either of 
these two lineage-defining factors could result in dramatic 
changes in gene expression networks and possibly have impli-
cations for plasticity between the Th1 and Tfh cell types.
In addition to Tfh cells, Bcl-6 has been implicated in the 
formation of both CD4+ and CD8+ memory T cells. Central 
memory T cells are characterized by reduced expression of 
Blimp1 as compared with effector memory T cells, which ex-
press high levels of Blimp1 (Kallies et al., 2009; Rutishauser   
et al., 2009). Importantly, Blimp1 and Bcl-6 negatively regu-
late each other’s expression, which results in an inverse corre-
lation between the two factors. Thus, central memory T cells 
with low Blimp1 should express higher levels of Bcl-6 in 
comparison with effector memory T cells. Interestingly, the 
cytokine production from a reactivated central memory T cell 
is indeed subdued in comparison with that of an effector 
memory T cell response (Kaech and Wherry, 2007). There-
fore, it is possible that the mechanisms described in this study 
could aid in tempering T-box protein–dependent cytokine 
production in central memory T cells.
It is also interesting to speculate about how the DNA 
binding–independent targeting of Bcl-6 to gene loci may dif-
ferentially affect gene expression patterns in different cell 
types.  To  date, 
microarray data-
sets  examining 
gene expression 
patterns between 
Additionally, Ifng promoter-reporter activity was higher in 
day 3 versus day 7 primary Th1 cells (Fig. 7 E). Importantly, 
Bcl-6  was  not  associated  with  the  Ifng  promoter  at  day   
3 when Ifng expression was approximately fivefold higher 
(Fig. 7 C). Therefore, the decrease in Ifng expression from day 
3 to 7 correlates with the T-bet–dependent recruitment of 
Bcl-6 to the Ifng promoter specifically at this late stage of 
Th1 differentiation.
To rule out the possibility that the lower levels of Ifng 
transcripts in the late stages of Th1 differentiation are caused 
by a reduction in T-bet binding to the Ifng promoter, we per-
formed a ChIP analysis on day 3 versus day 7 from WT and 
T-bet/ Th1 cells. In contrast to the decrease observed in Ifng 
transcripts at day 7, there was actually an increase in the amount 
of T-bet bound to the promoter at day 7 (Fig. 7 F). Thus, the 
amount of T-bet bound to the Ifng promoter does not explain 
the decrease in transcription. Collectively, these data suggest 
the mechanism by which Bcl-6 represses T-bet–dependent 
promoter activity may be important for inhibiting both genes 
that are activated and repressed by T-bet in Th1 cells.
DISCUSSION
In this study, we have identified three novel gene targets that 
are negatively regulated by T-bet in Th1 cells. Interestingly, the 
mechanism by which T-bet functionally represses these genes 
involves a physical association with the Tfh cell lineage–defining 
factor, Bcl-6. Bcl-6 is targeted by T-bet to the promoters of 
Socs1, Socs3, and Tcf7 and, once associated, represses the tran-
scriptional activation of these genes. Interestingly, Bcl-6 also 
antagonizes the T-bet–dependent activation of Ifng, a gene 
positively regulated by T-bet. Collectively, the data suggest 
that the interplay between T-bet and Bcl-6 is important for 
establishing appropriate gene expression patterns in Th1 cell 
development (Fig. 8).
Recently, the transcriptional repressor Bcl-6 was identi-
fied  as  a  key  factor  that  promotes Tfh  cell  differentiation 
(Johnston et al., 2009; Nurieva et al., 2009;  Yu et al., 2009a). 
In this study, we demonstrate that in differentiated Th1 cells, 
T-bet and Bcl-6 collaborate to repress the transcription of 
several genetic loci. Our findings, as well as others that demon-
strate the simultaneous expression of multiple lineage-defining 
Figure 8.  Models representing the mecha-
nisms by which T-bet and Bcl-6 cooperate to 
regulate transcription. (A) Schematic portraying 
the differences in the regulation of Socs1, Socs3, 
and Tcf7 genes in WT versus T-bet–deficient CD4+ 
T cells. In WT Th1 cells, T-bet–dependent targeting 
of Bcl-6 to the Socs1, Socs3, and Tcf7 promoters 
results in transcriptional repression. Conversely, 
the absence of T-bet in the T-bet/ Th1 cells 
results in a loss of Bcl-6 targeting to the Socs1, 
Socs3, and Tcf7 promoters and gene activation. 
(B) A schematic representation of Bcl-6 repres-
sion at the Ifng locus. In the naive CD4+ T cells, 
gray circles represent closed chromatin. By day 3 
of Th1 differentiation, T-bet binds to the pro-
moter and functionally induces chromatin  
remodeling, resulting in enhanced Ifng tran-
scription. By day 7 of Th1 differentiation, the 
reduced level of Ifng transcription correlates with 
the T-bet–dependent recruitment of Bcl-6 to the 
Ifng promoter.1010 T-bet and Bcl-6 cooperate to repress transcription | Oestreich et al.
IFN-. Previous studies examining Tfh cells found that when 
Bcl-6 is in excess during Tfh cell development, Ifng expres-
sion is significantly impaired (Nurieva et al., 2009; Yu et al., 
2009a). In addition, overexpression of Bcl-6 in primary T cells 
results in a modest decrease in Ifng transcription, whereas the 
absence of Bcl-6 results in a dramatic increase (Nurieva et al., 
2009). These observations were previously attributed to an 
indirect mechanism related to the ability of Bcl-6 to repress 
Tbx21 (the gene encoding T-bet). However, the absolute levels 
of T-bet did not always correlate with Ifng expression in these 
experiments, and this explanation also could not account for 
an initial reduction in Ifng before the down-regulation of   
T-bet (Nurieva et al., 2009). Our data now extend these find-
ings by identifying Ifng as a direct target of Bcl-6 repression. 
We demonstrate that Bcl-6 associates with the Ifng locus in a   
T-bet-dependent manner and inhibits its transcription at late 
time points in Th1 differentiation. Collectively, these data sug-
gest that the interplay between T-bet and Bcl-6 may help to en-
sure that the expression of Ifng remains at a moderate level so 
that there is neither too little, which would impede the initia-
tion of an appropriate immune response for pathogen clearance, 
nor too much, which could result in autoimmunity.
It is interesting to note the timing for the T-bet–dependent 
association of Bcl-6 with the Ifng promoter. Ifng transcript 
levels inversely correlate with the recruitment of Bcl-6 at 
later time points in Th1 differentiation. However, the envi-
ronmental or intracellular cues that prompt the targeting of 
Bcl-6 to the Ifng locus are currently unknown. The answers to 
these questions await a better understanding of the additional 
regulatory signaling pathways and complexes involved in this 
process. A comprehensive understanding of these mechanisms 
will provide insight into Th1 and Tfh cell fate choices and the 
potential for plasticity between these two Th cell fates. Col-
lectively, the study presented here provides evidence for a 
model  of  gene  regulation  in  which  two  lineage-defining 
transcription factors collaborate to promote the development 
of the Th1 cell fate by repressing genes that contribute to the 
differentiation of other Th cell types, as well as regulating the 
expression of genes necessary for the proper functioning of 
the Th1 cell.
MATERIALS AND METHODS
Cell culture and transfection
Primary T cells. Primary CD4+ T cells were isolated from the spleen and 
lymph nodes of WT and T-bet/ mice using the Mag Cellect kit (R&D 
Systems) as previously described (Beima et al., 2006). After isolation, cells 
were grown on plate-bound -CD3/-CD28 and treated with Th1 polariz-
ing cytokines: 5 µg/ml –IL-4, 5 ng/ml IL-12, and 10 ng/ml IL-2 (National 
Cancer Institute preclinical repository). On day 3, cells were split and treated 
under Th1 conditions for an additional 3 d. All experiments involving mice 
were  conducted  in  accordance  with  Institutional Animal  Care  and  Use 
Committee approval. For transfections involving primary cells, the Amaxa 
nucleofection system (Lonza) was used. Manufacturer protocols were fol-
lowed using mouse primary T cell solutions and program X-01.
EL4 T cells. Mouse EL4 T cells (American Type Culture Collection) were 
grown in RPMI with 10% FBS and penicillin/streptomycin. Cells were 
transfected using the Amaxa nucleofection system using program 0-17 and 
solution V as previously described (Beima et al., 2006). After transfection, the 
immune cell types that harbor high Bcl-6 expression levels 
contain few similarities (Johnston et al., 2009; Rutishauser   
et al., 2009). Our study demonstrates that some gene targets 
repressed by Bcl-6 are determined by its recruitment to T-bet 
binding sites rather than the DNA-binding capabilities of Bcl-6 
itself. Therefore, if the mechanisms described in this study are 
conserved in other cells types, Bcl-6 could be targeted to 
genetic loci based on the predominance of a particular tran-
scription factor, in this case, T-bet. This will then alter both   
T-bet and Bcl-6 target gene expression patterns to create a 
specialized profile for the cell.
The identification of Socs1, Socs3, and Tcf7 as genes that 
are negatively regulated by T-bet provides new insight into 
the gene expression network that is established during Th1 
development. Importantly, the repression of the Socs family 
members Socs1 and Socs3 is necessary to create a functional 
Th1 cell. Numerous studies have shown that Socs1 and Socs3 
repress the Th1 cell lineage and promote other Th cell types 
such as Th2 cells (Diehl et al., 2000; Egwuagu et al., 2002; 
Eyles et al., 2002; Seki et al., 2003). For Socs1, this is because 
of its role in inhibiting the IFN- and STAT1 signaling path-
way,  a  signaling  module  critical  for  the  development  and 
function of a Th1 cell (Sakamoto et al., 1998; Alexander et al., 
1999). Significantly, Socs1-deficient CD4+ T cells have a pro-
pensity to develop into Th1 cells, whereas overexpression of 
Socs1 inhibits the Th1 cell lineage (Diehl et al., 2000; Eyles   
et al., 2002). Similar to the role for Socs1 in antagonizing 
IFN- signaling, Socs3 plays an analogous role in disrupting 
STAT4 and IL-12 signaling, which is another pathway crucial 
for Th1 cell development (Seki et al., 2003; Yamamoto et al., 
2003; Takatori et al., 2005). Furthermore, Socs3 is preferentially 
expressed in the CD4+ T cells of the Th2 cell lineage (Egwuagu 
et al., 2002). Importantly, the dysregulation of Socs1 and Socs3 
has been linked to the onset of autoimmune diseases and some 
types of cancer, providing strong evidence for their biological 
significance in the proper regulation of the immune response 
(Cottet et al., 2001; Karlsen et al., 2001; He et al., 2003; Seki et 
al., 2003; Chong et al., 2004; Weniger et al., 2006). Collectively, 
the impact of Socs1 and Socs3 on immune cell function and its 
involvement in human disease highlights the importance in de-
termining the mechanisms governing their proper regulation, 
including the role of T-bet and Bcl-6 in this process.
Our experiments also identified Tcf7 as a target of T-bet–
mediated repression. Recently, the protein product of the   
Tcf7 gene, TCF-1, has been linked to the transcriptional regu-
lation of GATA-3, the lineage-defining factor for the Th2 
lineage (Yu et al., 2009b). TCF-1 promotes the development 
of the Th2 cell fate by promoting GATA-3 expression and 
repressing  IFN-  production. Therefore,  the  repression  of 
Tcf7 by T-bet will inhibit the Th2 fate. To underscore the bio-
logical significance of this, Tcf7 has been linked to the onset 
of Type 1 diabetes, a disease which has also been associated 
with dysregulation of T-bet and Th1 cells (Noble et al., 2003; 
Erlich et al., 2009).
Interestingly, our data also suggest that Bcl-6 is directly 
involved in the regulation of the canonical Th1 cytokine, JEM VOL. 208, May 9, 2011 
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Online supplemental material
Fig. S1 uses a chromatin accessibility assay to show that the T-bet–dependent 
repression of Socs1, Socs3, and Tcf7 is independent of the chromatin environ-
ment.  Fig.  S2  demonstrates  that  a T-bet  mutant  deficient  in  chromatin- 
remodeling capabilities is unable to activate the Socs1, Socs3, and Tcf7 
promoters. Fig. S3 is a schematic representation of the Socs1, Socs3, and Tcf7 
promoters displaying the locations of the T-bet and Bcl-6 binding sites. 
Fig. S4 is a promoter-reporter assay demonstrating an increase in Tcf7 and 
Ifng promoter activity when Bcl-6 levels are reduced. Fig. S5 is a Western blot 
analysis of the expression levels for the WT Bcl-6 and Bcl6DBmut constructs. 
Fig. S6 demonstrates that the overexpression of two unique Bcl6DBmut con-
structs represses Socs1 and Tcf7 promoter-reporter activity but not that of 
Gzmb. Fig. S7 shows that there is no alteration of Socs1 promoter activity in 
T-bet/ primary Th1 cells when T-bet binding sites are mutated. Fig. S8 
demonstrates that the expression levels of Bcl-6 are similar in WT and T-
bet/ primary Th1 cells. Fig. S9 is a promoter-reporter assay demonstrating 
the  requirement  for  both  the  BTB/POZ  and  C-terminal  zinc  finger   
domains in the repression of Tcf7 promoter activity by Bcl-6. Table S1 lists 
the primer sequences used in this study. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20102144/DC1.
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